| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 5, 1845-1852, Copyright © 1991 by Endocrine Society
ARTICLES |
WY Chen, DC Wight, BV Mehta, TE Wagner and JJ Kopchick
Department of Zoology, Ohio University, Athens 45701.
Bovine GH (bGH) analogs with single amino acid substitutions at positions 117 (bGH-E117L), 119 (bGH-G119R), and 122 (bGH-A122D) were generated. These analogs bind to mouse liver membrane preparations with affinities similar to native bGH. However, transgenic mice which express the analogs demonstrate different phenotypes ranging from dwarfism to gigantism. For example, expression of bGH or bGH-E117L result in large transgenic mice. In contrast, transgenic mice with a growth phenotype similar to nontransgenic animals result from expression of bGH-A122D. Surprisingly, transgenic mice with relatively high serum levels of bGH-G119R possessed a dwarf phenotype. Together these results suggest that Gly 119 and Ala 122 are involved in growth- promoting activity of GH.
This article has been cited by other articles:
![]() |
J.-B. Jomain, E. Tallet, I. Broutin, S. Hoos, J. van Agthoven, A. Ducruix, P. A. Kelly, B. B. Kragelund, P. England, and V. Goffin Structural and Thermodynamic Bases for the Design of Pure Prolactin Receptor Antagonists: X-RAY STRUCTURE OF Del1-9-G129R-hPRL J. Biol. Chem., November 9, 2007; 282(45): 33118 - 33131. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.R. Smid, J.E. Rowland, W.G. Young, K.T. Coschigano, J.J. Kopchick, and M.J. Waters Mouse Molar Dentin Size/Shape is Dependent on Growth Hormone Status J. Dent. Res., May 1, 2007; 86(5): 463 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Davies, E. F. Gevers, A. E. Stevenson, K. T. Coschigano, M. M. El-Kasti, M. J. Bull, C. Elford, B. A. J. Evans, J. J. Kopchick, and T. Wells Adiposity profile in the dwarf rat: an unusually lean model of profound growth hormone deficiency Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1483 - E1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. H. Schenck and C. L. Brooks Effects of an S84E Mutation of Bovine Growth Hormone in Transgenic Mice. Experimental Biology and Medicine, March 1, 2006; 231(3): 296 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. O. Ramirez-Yanez, J. R. Smid, W. G. Young, and M. J. Waters Influence of growth hormone on the craniofacial complex of transgenic mice Eur J Orthod, October 1, 2005; 27(5): 494 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Smaniotto, V. de Mello-Coelho, D. M. S. Villa-Verde, J.-M. Pleau, M.-C. Postel-Vinay, M. Dardenne, and W. Savino Growth Hormone Modulates Thymocyte Development in Vivo through a Combined Action of Laminin and CXC Chemokine Ligand 12 Endocrinology, July 1, 2005; 146(7): 3005 - 3017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maamra, J. J. Kopchick, C. J. Strasburger, and R. J. M. Ross Pegvisomant, a Growth Hormone-Specific Antagonist, Undergoes Cellular Internalization J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4532 - 4537. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. E. Meyer, D. Korthaus, W. Jagla, E. Cornali, J. Grosse, H. Fuchs, M. Klingenspor, S. Roemheld, M. Tschop, G. Heldmaier, et al. A Novel Missense Mutation in the Mouse Growth Hormone Gene Causes Semidominant Dwarfism, Hyperghrelinemia, and Obesity Endocrinology, May 1, 2004; 145(5): 2531 - 2541. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Muller, J. J. Kopchick, A. Flyvbjerg, and A. J. van der Lely Growth Hormone Receptor Antagonists J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1503 - 1511. [Full Text] [PDF] |
||||
![]() |
K. Iida, J. P. Del Rincon, D.-S. Kim, E. Itoh, R. Nass, K. T. Coschigano, J. J. Kopchick, and M. O. Thorner Tissue-Specific Regulation of Growth Hormone (GH) Receptor and Insulin-Like Growth Factor-I Gene Expression in the Pituitary and Liver of GH-Deficient (lit/lit) Mice and Transgenic Mice that Overexpress Bovine GH (bGH) or a bGH Antagonist Endocrinology, April 1, 2004; 145(4): 1564 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.R. Smid, J.E. Rowland, W.G. Young, T.J. Daley, K.T. Coschigano, J.J. Kopchick, and M.J. Waters Mouse Cellular Cementum is Highly Dependent on Growth Hormone Status J. Dent. Res., January 1, 2004; 83(1): 35 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Belecky-Adams, M. Holmes, Y. Shan, C. S. Tedesco, C. Mascari, A. Kaul, D. C. Wight, R. E. Morris, M. Sussman, J. Diamond, et al. An Intact Intermediate Filament Network Is Required for Collateral Sprouting of Small Diameter Nerve Fibers J. Neurosci., October 15, 2003; 23(28): 9312 - 9319. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Coschigano, A. N. Holland, M. E. Riders, E. O. List, A. Flyvbjerg, and J. J. Kopchick Deletion, But Not Antagonism, of the Mouse Growth Hormone Receptor Results in Severely Decreased Body Weights, Insulin, and Insulin-Like Growth Factor I Levels and Increased Life Span Endocrinology, September 1, 2003; 144(9): 3799 - 3810. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. R. Knapp, and J. J. Kopchick Enlargement of Interscapular Brown Adipose Tissue in Growth Hormone Antagonist Transgenic and in Growth Hormone Receptor Gene-Disrupted Dwarf Mice Experimental Biology and Medicine, February 1, 2003; 228(2): 207 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kopchick, C. Parkinson, E. C. Stevens, and P. J. Trainer Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly Endocr. Rev., October 1, 2002; 23(5): 623 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, W. Li, L. Holle, N. Chen, and W. Y. Chen A Novel Design of Targeted Endocrine and Cytokine Therapy for Breast Cancer Clin. Cancer Res., April 1, 2002; 8(4): 1196 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Frank Minireview: Receptor Dimerization in GH and Erythropoietin Action--It Takes Two to Tango, But How? Endocrinology, January 1, 2002; 143(1): 2 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, B. Kelder, and J. J. Kopchick Identification, Isolation, and Cloning of Growth Hormone (GH)-Inducible Interscapular Brown Adipose Complementary Deoxyribonucleic Acid from GH Antagonist Mice Endocrinology, July 1, 2001; 142(7): 2937 - 2945. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Kaulsay, T. Zhu, W. F. Bennett, K.-O. Lee, and P. E. Lobie The Effects of Autocrine Human Growth Hormone (hGH) on Human Mammary Carcinoma Cell Behavior Are Mediated via the hGH Receptor Endocrinology, February 1, 2001; 142(2): 767 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Turner, J. R. Knapp, F. M. Byers, and J. J. Kopchick Physical and Mechanical Characteristics of Tibias from Transgenic Mice Expressing Mutant Bovine Growth Hormone Genes Experimental Biology and Medicine, February 1, 2001; 226(2): 133 - 139. [Abstract] [Full Text] |
||||
![]() |
S. H. Zarkesh-Esfahani, O. Kolstad, R. A. Metcalfe, P. F. Watson, S. Von Laue, S. Walters, A. Revhaug, A. P. Weetman, and R. J. M. Ross High-Dose Growth Hormone Does Not Affect Proinflammatory Cytokine (Tumor Necrosis Factor-{alpha}, Interleukin-6, and Interferon-{gamma}) Release from Activated Peripheral Blood Mononuclear Cells or after Minimal to Moderate Surgical Stress J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3383 - 3390. [Abstract] [Full Text] |
||||
![]() |
K. T. Coschigano, D. Clemmons, L. L. Bellush, and J. J. Kopchick Assessment of Growth Parameters and Life Span of GHR/BP Gene-Disrupted Mice Endocrinology, July 1, 2000; 141(7): 2608 - 2613. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Asa, K. T. Coschigano, L. Bellush, J. J. Kopchick, and S. Ezzat Evidence for Growth Hormone (GH) Autoregulation in Pituitary Somatotrophs in GH Antagonist-Transgenic Mice and GH Receptor-Deficient Mice Am. J. Pathol., March 1, 2000; 156(3): 1009 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Bellush, S. Doublier, A. N. Holland, L. J. Striker, G. E. Striker, and J. J. Kopchick Protection against Diabetes-Induced Nephropathy in Growth Hormone Receptor/Binding Protein Gene-Disrupted Mice Endocrinology, January 1, 2000; 141(1): 163 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. Jiang, J. J. Kopchick, and S. J. Frank Disulfide Linkage of Growth Hormone (GH) Receptors (GHR) Reflects GH-induced GHR Dimerization. ASSOCIATION OF JAK2 WITH THE GHR IS ENHANCED BY RECEPTOR DIMERIZATION J. Biol. Chem., November 12, 1999; 274(46): 33072 - 33084. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bartke, V. Chandrashekar, D. Turyn, R. W. Steger, L. Debeljuk, T. A. Winters, J. A. Mattison, N. A. Danilovich, W. Croson, D. R. Wernsing, et al. Effects of Growth Hormone Overexpression and Growth Hormone Resistance on Neuroendocrine and Reproductive Functions in Transgenic and Knock-Out Mice Experimental Biology and Medicine, November 1, 1999; 222(2): 113 - 123. [Abstract] [Full Text] |
||||
![]() |
W. Y. Chen, P. Ramamoorthy, N.-y. Chen, R. Sticca, and T. E. Wagner A Human Prolactin Antagonist, hPRL-G129R, Inhibits Breast Cancer Cell Proliferation through Induction of Apoptosis Clin. Cancer Res., November 1, 1999; 5(11): 3583 - 3593. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ruan, L. Powell-Braxton, J. J. Kopchick, and D. L. Kleinberg Evidence That Insulin-Like Growth Factor I and Growth Hormone Are Required for Prostate Gland Development Endocrinology, May 1, 1999; 140(5): 1984 - 1989. [Abstract] [Full Text] |
||||
![]() |
D. Helman, N. R. Staten, J. Grosclaude, N. Daniel, C. Nespoulous, J. Djiane, and A. Gertler Novel Recombinant Analogues of Bovine Placental Lactogen. G133K AND G133R PROVIDE A TOOL TO UNDERSTAND THE DIFFERENCE BETWEEN THE ACTION OF PROLACTIN AND GROWTH HORMONE RECEPTORS J. Biol. Chem., June 26, 1998; 273(26): 16067 - 16074. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Turner, J. R. Knapp, F. M. Byers, and J. J. Kopchick Expression of Mutant Bovine Growth Hormone Genes in Mice Perturbs Age-Related Nutrient Utilization Patterns J. Nutr., March 1, 1998; 128(3): 520 - 524. [Abstract] [Full Text] |
||||
![]() |
L. E. Smith, J. J. Kopchick, W. Chen, J. Knapp, F. Kinose, D. Daley, E. Foley, R. G. Smith, and J. M. Schaeffer Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization Science, June 13, 1997; 276(5319): 1706 - 1709. [Abstract] [Full Text] |
||||
![]() |
V. Goffin, S. Kinet, F. Ferrag, N. Binart, J. A. Martial, and P. A. Kelly Antagonistic Properties of Human Prolactin Analogs That Show Paradoxical Agonistic Activity in the Nb2 Bioassay J. Biol. Chem., July 12, 1996; 271(28): 16573 - 16579. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Harding, X. Wang, S. Okada, W. Y. Chen, W. Wan, and J. J. Kopchick Growth Hormone (GH) and a GH Antagonist Promote GH Receptor Dimerization and Internalization J. Biol. Chem., March 22, 1996; 271(12): 6708 - 6712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Dattani, P. C. Hindmarsh, C. G. D. Brook, I. C. A. F. Robinson, J. J. Kopchick, and N. J. Marshall G120R, a Human Growth Hormone Antagonist, Shows Zinc-dependent Agonist and Antagonist Activity on Nb2 Cells J. Biol. Chem., April 21, 1995; 270(16): 9222 - 9226. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fuh, B. C. Cunningham, R. Fukunaga, S. Nagata, D. V. Goeddel, and J. A. Wells Rational Design of Potent Antagonists to the Human Growth Hormone Receptor Science, June 19, 1992; 256(5064): 1677 - 1680. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |